DRTSAlpha Tau Medical Ltd.
$14.43+253% 1Y
$14.43
$3.4752 weeks$15.51
DRTS as reported
- Net income
- −$43M
Net income · +34% year on year · trailing twelve months to FY2025
- Free cash flow
- −$33M
Free cash flow · +49% year on year · trailing twelve months to FY2025
- EPS
- −$0.53
EPS · +18% year on year · trailing twelve months to FY2025
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$43M | +34% | FY2025 |
| EPS | −$0.53 | +18% | FY2025 |
| ROE | −55% | n/a | FY2025 |
| ROA | −40% | n/a | FY2025 |
| Free cash flow | −$33M | +49% | FY2025 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Alpha Tau Medical Ltd. (DRTS) · Net incomeNet incomeAlpha Tau Medical Ltd. (DRTS)